B. Braun Announces Joint Venture with Next-Gen Sequencing Company

B. Braun, a global medical device manufacturer and pharmaceutical company located in the Lehigh Valley of Pennsylvania, announced a joint venture with German company CeGaT GmbH on next-generation sequencing technology, which it seeks to establish as the standard of diagnostic care for a variety of cancers, neuromuscular diseases, and epilepsy. The technology sequences DNA and RNA quickly and affordably, which helps doctors customize their treatment to specific conditions. Read more

Story Location